AMPLY’s AI drug discovery platform was developed to ensure new generations of antibiotics remain effective against infections.
AMPLY has raised €4.2M across 3 funding rounds from 12 investors, most recently a Seed round in May 2025. Based in Belfast, Ireland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-02 | Seed | €1.5M | Co-Fund NI,QUBIS Limited,The British Business Bank,Twin Path Ventures,Venture Science | View deal → |
| 2024-02-12 | Grant | €1.6M | Innosuisse,Innovate UK | View deal → |
| 2022-09-21 | Other | €1.0M | British Business Investments,Co fund NI,Halo Business Angel Network,Helix Way Partnership,QUBIS Innovation Fund | View deal → |
